Crown Laboratories Now Operates Under the Name Revance

May 2, 2025

Crown Laboratories, Inc. has announced that it will operate under the name Revance, a name that best represents the newly combined company mission to revolutionize the aesthetics and skincare industry through science-based, innovative products.

This change marks a significant milestone in the company’s strategic transformation following its recent acquisition of Revance Therapeutics, Inc., a biotechnology company known for its cutting-edge innovation in aesthetics and therapeutics, which joins Crown’s deep roots in science-driven brands for skin health and rejuvenation.

About Revance
Revance is a fast-growing global aesthetics and skincare company focused on providing innovative aesthetics and market-leading skincare offerings throughout every stage of life. With a differentiated portfolio of products spanning 60 countries, Revance meets the evolving needs of patients and consumers worldwide through continued innovation and commercialization of new products and treatments.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • South Carolina Medical Board Warns Against Use of Research-Grade Peptides
    • Lilly Sues Six Companies Over Alleged Sales of Experimental Weight-Loss Drug Retatrutide
    • DaySpark Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics Refreshes Allergan Partner Privileges to Better Support Today’s Modern Aesthetics Practices
    • Galderma Receives EU Approval for Restylane Shaype: Bone-Mimicking Hyaluronic Acid Injectable for Chin